Convergence Investment Partners LLC lessened its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 85.5% during the 1st quarter, HoldingsChannel reports. The firm owned 428 shares of the company’s stock after selling 2,526 shares during the period. Convergence Investment Partners LLC’s holdings in HCA Healthcare were worth $202,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Palisade Asset Management LLC purchased a new stake in HCA Healthcare during the 3rd quarter valued at about $26,000. Ares Financial Consulting LLC acquired a new position in shares of HCA Healthcare during the 4th quarter worth approximately $31,000. Cedar Mountain Advisors LLC acquired a new stake in shares of HCA Healthcare in the first quarter valued at approximately $33,000. JPL Wealth Management LLC acquired a new position in HCA Healthcare during the third quarter worth $33,000. Finally, MCF Advisors LLC increased its stake in shares of HCA Healthcare by 213.0% in the 4th quarter. MCF Advisors LLC now owns 72 shares of the company’s stock worth $34,000 after acquiring an additional 49 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of brokerages recently issued reports on HCA. Barclays dropped their price objective on shares of HCA Healthcare from $427.00 to $402.00 and set an “equal weight” rating for the company in a report on Thursday, July 16th. Oppenheimer cut their price target on shares of HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating for the company in a report on Monday, April 27th. Deutsche Bank Aktiengesellschaft decreased their price objective on HCA Healthcare from $558.00 to $540.00 and set a “buy” rating on the stock in a report on Tuesday, April 28th. Leerink Partners reduced their target price on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a research report on Monday, April 27th. Finally, Truist Financial set a $413.00 price target on HCA Healthcare in a report on Thursday, June 4th. Fourteen research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average target price of $483.45.
HCA Healthcare Trading Down 0.1%
Shares of NYSE HCA opened at $372.58 on Thursday. The stock has a fifty day simple moving average of $388.88 and a 200-day simple moving average of $454.89. HCA Healthcare, Inc. has a twelve month low of $330.00 and a twelve month high of $556.52. The stock has a market capitalization of $82.65 billion, a PE ratio of 12.81, a PEG ratio of 1.26 and a beta of 1.12.
HCA Healthcare (NYSE:HCA – Get Free Report) last announced its earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The firm had revenue of $19.11 billion for the quarter, compared to analysts’ expectations of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business’s revenue was up 4.3% compared to the same quarter last year. During the same quarter last year, the business earned $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities analysts predict that HCA Healthcare, Inc. will post 29.19 earnings per share for the current year.
HCA Healthcare Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th were paid a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend was Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is presently 10.73%.
Trending Headlines about HCA Healthcare
Here are the key news stories impacting HCA Healthcare this week:
- Negative Sentiment: Multiple plaintiff law firms have launched investigations into HCA Healthcare over possible securities-law violations, increasing headline risk and investor uncertainty. HCA Healthcare, Inc. Investigated by the Portnoy Law Firm
- Negative Sentiment: Bragar Eagel & Squire is also investigating HCA on behalf of stockholders, adding to the cluster of legal inquiries that could pressure the shares. HCA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating HCA Healthcare, Inc.
- Negative Sentiment: Pomerantz LLP has opened a similar investigation, reinforcing concerns that the stock could face further legal scrutiny. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. – HCA
- Negative Sentiment: Kessler Topaz Meltzer & Check is likewise investigating HCA for potential federal securities-law violations, adding to the negative legal backdrop. NYSE: HCA Investigation: Kessler Topaz Meltzer & Check, LLP Encourages HCA Healthcare, Inc. Investors to Contact the Firm
- Neutral Sentiment: HCA Florida Lake Monroe Hospital welcomed 29 new resident physicians, a routine operational update that is unlikely to move the stock on its own. HCA Florida Lake Monroe Hospital welcomes 29 new resident physicians
- Neutral Sentiment: HCA also highlighted leadership and project updates at several facilities, including promotions and new CMO appointments, which are more operational than market-moving. HCA Florida promotes CEO of 2 hospitals Arabinda Pani joins HCA Houston Healthcare Kingwood as CMO Think big: HCA rep. updates Rotary on Long Pt. ER and other projects
- Negative Sentiment: An HCA Georgia hospital paused most services amid flooding, which could create near-term operational disruption and reputational concerns. HCA Georgia hospital pauses most services amid flooding
- Neutral Sentiment: A story on HCA’s enterprise AI strategy was largely informational and highlights longer-term efficiency efforts rather than an immediate earnings catalyst. How HCA Healthcare built its enterprise AI strategy
About HCA Healthcare
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Further Reading
- Five stocks we like better than HCA Healthcare
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
